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Neurodegenerative diseases result from deterioration of neurons or their myelin sheath 
that over time leads to brain dysfunction and premature death. Cells of the brain and 
spinal cord do not readily regenerate therefore excessive damage can be devastating. 
Our lab focuses on stem cell-based therapies for brain disorders. Previous studies 
indicate the potential of stem cells for use in therapies to treat neurodegenerative 
disorders. In particular, my lab project deals with dental pulp mesenchymal stem cells 
(DPMSCs) that are currently being investigated due to their ability to differentiate into 
multiple cell types, including neural cells. Our DPMSCs are composed of populations of 
mesenchymal stem cells harvested from normal human third molars (wisdom teeth). 
The initial goal of my research is to assess the variation of marker expression by the 
dental pulp mesenchymal stem cells to describe their developmental potentials, 
particularly neuronal development since neurons are the functional unit of the brain. Our 
results identified expression of neuronal-specific markers (indicative of neuronal 
precursors and mature neurons) at the gene and protein level by the DPMSCs 
specifically, we observed expression of nestin, β-III tubulin, and GFAP as well as the 
MSC markers CD 90, CD 73 and CD 44. Based on these findings, we propose that 
human DPMSCs may possess the capabilities necessary for therapeutic treatment of 
neurodegenerative disorders. In future experiments, we plan to perform cell 
transplantations into mouse models with neurodegenerative disorders. Our results are 
very significant because they could lead to cures for serious CNS disorders. 
